Literature DB >> 33871175

Applying Administrative Data-Based Coding Algorithms for Frailty in Patients With Cirrhosis.

Jeremy Louissaint1, Susan L Murphy2,3, Christopher J Sonnenday4, Anna S Lok1, Elliot B Tapper1,2,5.   

Abstract

Frailty is a powerful prognostic tool in cirrhosis. Claims-based frailty scores estimate the presence of frailty without the need for in-person evaluation. These algorithms have not been validated in cirrhosis. Whether they measure true frailty or perform as well as frailty in outcome prediction is unknown. We evaluated 2 claims-based frailty scores-Hospital Frailty Risk Score (HFRS) and Claims-Based Frailty Index (CFI)-in 3 prospective cohorts comprising 1100 patients with cirrhosis. We assessed differences in neuromuscular/neurocognitive capabilities in those classified as frail or nonfrail based on each score. We assessed the ability of the indexes to discriminate frailty based on the Fried Frailty Index (FFI), chair stands, activities of daily living (ADL), and falls. Finally, we compared the performance of claims-based frailty measures and physical frailty measures to predict transplant-free survival using competing risk regression and patient-reported outcomes. The CFI identified neuromuscular deficits (balance, chair stands, hip strength), whereas the HFRS only identified poor chair-stand performance. The CFI had areas under the receiver operating characteristic curve (AUROCs) for identifying frailty as measured by the FFI, ADL, and falls of 0.57, 0.60, and 0.68, respectively; similarly, the AUROCs were 0.66, 0.63, and 0.67, respectively, for the HFRS. Claims-based frailty scores were associated with poor quality of life and sleep but were outperformed by the FFI and chair stands. The HFRS, per 10-point increase (but not the CFI) predicted survival of patients in the liver transplantation (subdistribution hazard ratio [SHR], 1.08; 95% confidence interval [CI], 1.03-1.12) and non-liver transplantation cohorts (SHR, 1.13; 95% CI, 1.05-1.22). Claims-based frailty scores do not adequately associate with physical frailty but are associated with important cirrhosis-related outcomes.
Copyright © 2021 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2021        PMID: 33871175      PMCID: PMC8994168          DOI: 10.1002/lt.26078

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  24 in total

1.  Report from the American Society of Transplantation on frailty in solid organ transplantation.

Authors:  Jon Kobashigawa; Darshana Dadhania; Sangeeta Bhorade; Deborah Adey; Joseph Berger; Geetha Bhat; Marie Budev; Andres Duarte-Rojo; Michael Dunn; Shelley Hall; Meera N Harhay; Kirsten L Johansen; Susan Joseph; Cassie C Kennedy; Evan Kransdorf; Krista L Lentine; Raymond J Lynch; Mara McAdams-DeMarco; Shunji Nagai; Michael Olymbios; Jignesh Patel; Sean Pinney; Joanna Schaenman; Dorry L Segev; Palak Shah; Lianne G Singer; Jonathan P Singer; Christopher Sonnenday; Puneeta Tandon; Elliot Tapper; Stefan G Tullius; Michael Wilson; Martin Zamora; Jennifer C Lai
Journal:  Am J Transplant       Date:  2018-12-22       Impact factor: 8.086

2.  Validation of a Claims-Based Frailty Index Against Physical Performance and Adverse Health Outcomes in the Health and Retirement Study.

Authors:  Dae Hyun Kim; Robert J Glynn; Jerry Avorn; Lewis A Lipsitz; Kenneth Rockwood; Ajinkya Pawar; Sebastian Schneeweiss
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2019-07-12       Impact factor: 6.053

3.  Development of a novel frailty index to predict mortality in patients with end-stage liver disease.

Authors:  Jennifer C Lai; Kenneth E Covinsky; Jennifer L Dodge; W John Boscardin; Dorry L Segev; John P Roberts; Sandy Feng
Journal:  Hepatology       Date:  2017-06-28       Impact factor: 17.425

4.  Measuring Frailty in Administrative Claims Data: Comparative Performance of Four Claims-Based Frailty Measures in the U.S. Medicare Data.

Authors:  Dae Hyun Kim; Elisabetta Patorno; Ajinkya Pawar; Hemin Lee; Sebastian Schneeweiss; Robert J Glynn
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-05-22       Impact factor: 6.053

5.  Frailty as Tested by Gait Speed is an Independent Risk Factor for Cirrhosis Complications that Require Hospitalization.

Authors:  Michael A Dunn; Deborah A Josbeno; Amit D Tevar; Vikrant Rachakonda; Swaytha R Ganesh; Amy R Schmotzer; Elizabeth A Kallenborn; Jaideep Behari; Douglas P Landsittel; Andrea F DiMartini; Anthony Delitto
Journal:  Am J Gastroenterol       Date:  2016-08-30       Impact factor: 10.864

6.  Frailty predicts waitlist mortality in liver transplant candidates.

Authors:  J C Lai; S Feng; N A Terrault; B Lizaola; H Hayssen; K Covinsky
Journal:  Am J Transplant       Date:  2014-06-16       Impact factor: 8.086

7.  Hepatic encephalopathy impacts the predictive value of the Fried Frailty Index.

Authors:  Elliot B Tapper; Monica Konerman; Susan Murphy; Christopher J Sonnenday
Journal:  Am J Transplant       Date:  2018-08-13       Impact factor: 8.086

8.  Frailty, Psychoactive Medications, and Cognitive Dysfunction Are Associated With Poor Patient-Reported Outcomes in Cirrhosis.

Authors:  Elliot B Tapper; Jad Baki; Neehar D Parikh; Anna S Lok
Journal:  Hepatology       Date:  2019-02-19       Impact factor: 17.425

9.  Frailty is independently associated with increased hospitalisation days in patients on the liver transplant waitlist.

Authors:  Marie Sinclair; Eduard Poltavskiy; Jennifer L Dodge; Jennifer C Lai
Journal:  World J Gastroenterol       Date:  2017-02-07       Impact factor: 5.742

10.  Validation of the hospital frailty risk score in a tertiary care hospital in Switzerland: results of a prospective, observational study.

Authors:  Andreas Eckart; Stephanie Isabelle Hauser; Sebastian Haubitz; Tristan Struja; Alexander Kutz; Daniel Koch; Olivia Neeser; Marc A Meier; Beat Mueller; Philipp Schuetz
Journal:  BMJ Open       Date:  2019-01-15       Impact factor: 2.692

View more
  1 in total

Review 1.  Best Practices in Large Database Clinical Epidemiology Research in Hepatology: Barriers and Opportunities.

Authors:  Nadim Mahmud; David S Goldberg; Therese Bittermann
Journal:  Liver Transpl       Date:  2021-08-07       Impact factor: 5.799

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.